上海金畔生物科技有限公司提供天然产物萜类及其苷类Terpenoids and Glycosides。
Rosamultin (Synonyms: 罗莎白素) 纯度: 99.00%
Rosamultin 是一种从 Potentilla anserina L 分离出的 19 α-羟基型三萜。 Rosamultin 对 HIV-1 Protease 具有抑制作用。 Rosamultin 具有抗氧化和抗凋亡作用,具有研究 H2O2 引起的氧化应激损伤的潜力。
Rosamultin Chemical Structure
CAS No. : 88515-58-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥3360 | In-stock | |
10 mg | ¥5710 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
Rosamultin 相关产品
•相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Anti-Infection Compound Library
- Metabolism/Protease Compound Library
- Natural Product Library
- Anti-Aging Compound Library
- Glycoside Compound Library
- Oxygen Sensing Compound Library
- Terpenoids Library
- Traditional Chinese Medicine Monomer Library
- Anti-Parkinson’s Disease Compound Library
- Neurodegenerative Disease-related Compound Library
生物活性 |
Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina L. Rosamultin has inhibitory effects against HIV-1 protease[1]. Rosamultin has the potential for treating H2O2-induced oxidative stress injury through its antioxidant and antiapoptosis effects[2]. |
IC50 & Target |
IC50: HIV-1 protease[1] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Rosamultin isolated from the root of R. rugosa inhibits HIV-1 protease by 53% at a concentration of 100 μM[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
650.84 |
||||||||||||||||
Formula |
C36H58O10 |
||||||||||||||||
CAS 号 |
88515-58-6 |
||||||||||||||||
中文名称 |
罗莎白素 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (153.65 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|